Literature DB >> 17638669

Chronic lymphocytic leukemia FISH panel: impact on diagnosis.

Beverly P Nelson1, Rohit Gupta, Gordon W Dewald, Sarah F Paternoster, Steven T Rosen, LoAnn C Peterson.   

Abstract

Interphase fluorescence in situ hybridization (FISH) is an alternative to conventional chromosome analysis of chronic lymphocytic leukemia (CLL) cells. We analyzed 172 samples from 136 possible CLL cases using a FISH panel. Reflex testing with probes to CCND1, BCL2, BCL3, BCL11A, c-MYC, MALT1, and a break-apart immunoglobulin heavy chain (IGH) probe was done if more than 2 signals for 14q32 occurred. For 111 cases, there were sufficient data for analysis. Of 111 cases, 81 (72.9%) had 1 or more genetic abnormalities. The most frequent abnormality was 13q-, followed by trisomy 12, 11q-, and 17p-. In 13 cases, there were IGH abnormalities. Two cases with CCND1/IGH fusion were reclassified as mantle cell lymphoma. Four CLL cases had IGH fusion with BCL2, BCL3 (2 cases), and BCL11A; no fusion partner was detected in 7 cases. Morphologic features were atypical for CLL in 2 cases with IGH fusion (BCL11A and BCL3). The FISH CLL panel is useful to identify prognostic aberrations and to clarify diagnosis in cases with unusual morphologic features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638669     DOI: 10.1309/21TN2RUWKR827UW2

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  12 in total

1.  Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.

Authors:  Douglas E Gladstone; Lode Swinnen; Yvette Kasamon; Amanda Blackford; Christopher D Gocke; Constance A Griffin; Javier Bolanos Meade; Richard J Jones
Journal:  Leuk Lymphoma       Date:  2011-08-18

2.  Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes.

Authors:  Grace A Ward; Kathy L McGraw; Farnoosh Abbas-Aghababazadeh; Benjamin S Meyer; Amy F McLemore; Nicole D Vincelette; Nghi B Lam; Amy L Aldrich; Najla H Al Ali; Eric Padron; Javier Pinilla-Ibarz; Erico Masala; Valeria Santini; Olivier Kosmider; Michaela Fontenay; Pierre Fenaux; Joseph Johnson; Brooke L Fridley; Alan F List
Journal:  Blood Adv       Date:  2021-04-27

3.  Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy.

Authors:  Neil E Kay; Jeanette E Eckel-Passow; Esteban Braggio; Scott Vanwier; Tait D Shanafelt; Daniel L Van Dyke; Diane F Jelinek; Renee C Tschumper; Thomas Kipps; John C Byrd; Rafael Fonseca
Journal:  Cancer Genet Cytogenet       Date:  2010-12

4.  Co-existence of t(6;13)(p21;q14.1) and trisomy 12 in chronic lymphocytic leukemia.

Authors:  Fábio Morato de Oliveira; Lorena Lobo de Figueiredo Pontes; Sarah Cristina Bassi; Leandro Felipe Figueiredo Dalmazzo; Roberto Passetto Falcão
Journal:  Med Oncol       Date:  2011-04-29       Impact factor: 3.064

5.  Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

Authors:  Marc DE Braekeleer; Corine Tous; Nadia Guéganic; Marie-Josée LE Bris; Audrey Basinko; Frédéric Morel; Nathalie Douet-Guilbert
Journal:  Mol Clin Oncol       Date:  2016-02-26

Review 6.  Prognostic Factors in the Era of Targeted Therapies in CLL.

Authors:  Prajwal Boddu; Alessandra Ferrajoli
Journal:  Curr Hematol Malig Rep       Date:  2018-04       Impact factor: 3.952

7.  Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer.

Authors:  Alexis Rivas; Verónica Burzio; Eduardo Landerer; Vincenzo Borgna; Sebastian Gatica; Rodolfo Ávila; Constanza López; Claudio Villota; Rodrigo de la Fuente; Javiera Echenique; Luis O Burzio; Jaime Villegas
Journal:  BMC Urol       Date:  2012-12-18       Impact factor: 2.264

8.  Partial trisomy 13q22-qter associated to leukoencephalopathy and late onset generalised epilepsy.

Authors:  Renee Ribacoba; Manuel Menendez-Gonzalez; Ines Hernando; Javier Salas; Maria Luisa Giros
Journal:  Int Arch Med       Date:  2008-04-29

9.  Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality.

Authors:  Ghaleb Elyamany; Kamal Fadalla; Hatem Elghezal; Omar Alsuhaibani; Hani Osman; Abdulaziz Al-Abulaaly
Journal:  Clin Med Insights Pathol       Date:  2014-09-23

10.  Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.

Authors:  Jung-Ah Kim; Byungjin Hwang; Si Nae Park; Sunghoon Huh; Kyongok Im; Sungbin Choi; Hye Yoon Chung; JooRyung Huh; Eul-Ju Seo; Je-Hwan Lee; Duhee Bang; Dong Soon Lee
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.